Literature DB >> 21326965

Serum protein electrophoresis: any role in monitoring for antiretroviral therapy?

Y S Sarro1, A Tounkara, E Tangara, O Guindo, H L White, E Chamot, S Kristensen.   

Abstract

BACKGROUND: Developing world are always looking for monitoring tools during reagent shortage and equipments troubles which are very frequent. The aim of this study was to evaluate Serum Protein Electrophoresis (SPE) as a marker for assessing HIV treatment response.
METHODS: A cross-sectional study was conducted with 220 participants in four distinct groups: Symptomatic HIV positive patients [specifically those on antiretroviral treatment (ART) versus those not on ART] asymptomatic HIV positive patients, and healthy blood donors. Five serum protein fractions (Albumin, Alpha-1, Alpha-2, Beta, and Gamma) were compared between these groups after measuring the density of the fractions.
RESULTS: Concentration of gamma globulin was lowest among healthy blood donors, intermediate and comparable among asymptomatic HIV positive and symptomatic HIV positive on ART and highest among untreated symptomatic HIV positive. Concentration of gamma globulin was inversely correlated with the disease stage (p < 0.001).
CONCLUSION: In this study, conducted in a setting where the burden of infectious diseases is high, the density of gamma globulin and albumin fractions were significantly associated with HIV status, and among HIV positive patients, with stage of HIV disease and ART. These results suggest that the feasibility of using SPE for monitoring the response of ART in low resource settings should be further explored.

Entities:  

Keywords:  Anti-Retroviral Therapy (ARV); HIV; Mali; Serum Protein Electrophoresis (SPE)

Mesh:

Substances:

Year:  2010        PMID: 21326965      PMCID: PMC2956280     

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  7 in total

1.  Serum protein electrophoresis in HIV seropositive and seronegative pregnant women.

Authors:  L C Kapsenberg; H S Cronjé; H van Jaarsveld
Journal:  Int J Gynaecol Obstet       Date:  2004-03       Impact factor: 3.561

2.  [Hemostasis anomalies and human immunodeficiency virus infection: what significance?].

Authors:  J G Fuzibet
Journal:  Rev Med Interne       Date:  1996       Impact factor: 0.728

3.  Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections.

Authors:  Lukas Hunziker; Mike Recher; Andrew J Macpherson; Adrian Ciurea; Stefan Freigang; Hans Hengartner; Rolf M Zinkernagel
Journal:  Nat Immunol       Date:  2003-03-10       Impact factor: 25.606

Review 4.  [Hemostasis anomalies and human immunodeficiency virus infection].

Authors:  H Fezoui; G Garnier; B Taillan; J P Cassuto; A Pesce
Journal:  Rev Med Interne       Date:  1996       Impact factor: 0.728

5.  Haematological abnormalities in the acquired immunodeficiency syndrome.

Authors:  F J Raal; E M Wypkema; R D Baynes
Journal:  S Afr Med J       Date:  1988-08-20

6.  Assessment of serum protein electrophoresis for monitoring therapy of naturally acquired equine cyathostomin infections.

Authors:  J B Abbott; D J Mellor; S Love
Journal:  Vet Parasitol       Date:  2007-04-25       Impact factor: 2.738

7.  [Serum immunoglobulins in children perinatally exposed to human immunodeficiency virus]

Authors:  M T Silva; M Centeville; S M Tani; A A Toro; C Rossi; M M Vilela
Journal:  J Pediatr (Rio J)       Date:  2001 May-Jun       Impact factor: 2.197

  7 in total
  2 in total

1.  Oral Recombinant Feline Interferon-Omega as an alternative immune modulation therapy in FIV positive cats: clinical and laboratory evaluation.

Authors:  S Gil; R O Leal; D McGahie; N Sepúlveda; A Duarte; M M R E Niza; L Tavares
Journal:  Res Vet Sci       Date:  2013-11-25       Impact factor: 2.534

2.  Serum protein electrophoresis pattern in patients living with HIV: frequency of possible abnormalities in Iranian patients.

Authors:  Zohreh Nozarian; Vahid Mehrtash; Alireza Abdollahi; Saloomeh Aeinehsazi; Atieh Khorsand; Arezoo Eftekhar-Javadi; Masoumeh Safaei; Fatemeh Nili
Journal:  Iran J Microbiol       Date:  2019-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.